Results 291 to 300 of about 472,200 (335)

Sex and Racial/Ethnic Differences in End‐of‐Life Care Preferences in Persons with Parkinson's Disease and Related Disorders

open access: yesMovement Disorders, EarlyView.
Abstract Background In persons with Parkinson's disease (PD) and related disorders (PDRD), rates of end‐of‐life (EoL) hospitalization are greatest, and rates of hospice utilization lowest, among men and persons of color. Reasons for these differences are unknown.
Whitley W. Aamodt   +7 more
wiley   +1 more source

Advancements in Magnesium Applications, Biocompatible Implants to Nanoparticles in Medicine and Biomedical Innovations

open access: yesMetalMat, Volume 2, Issue 2, June 2025.
Magnesium (Mg) and its alloys are identified as prospective materials for orthopedic and cardiovascular applications because of their bio‐corrosiveness and ability to stimulate tissue reparative processes. Although compared with traditional metals, Mg is biocompatible; however, it has various problems that stem from its biodegradation nature, for ...
Muhammad Mubeen   +6 more
wiley   +1 more source

Improving decomposition image quality in dual‐energy chest radiography using two‐dimensional crisscrossed anti‐scatter grid

open access: yesMedical Physics, EarlyView.
Abstract Background Chest radiography is a widely used medical imaging modality for diagnosing chest‐related diseases. However, anatomical structure overlap hinders accurate lesion detection. While the dual‐energy x‐ray imaging technique addresses this issue by separating soft‐tissue and bone images from an original chest radiograph, scattered ...
Duhee Jeon   +5 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Osteoporosis

Medicine, 2001
Osteoporosis affects an estimated 75 million people in Europe, the USA, and Japan combined (1). It is a preventable and a treatable condition, yet many patients with fractures remain unrecognized and untreated.
CIMAZ, ROLANDO, Biggioggero M.
  +8 more sources

[Osteoporosis].

Revue medicale suisse, 2005
Bone events related to bariatric surgery remain controversial. Denosumab, used in osteoporosis treatment, is safe and efficient. Romosozumab, an antibody raised against sclerostin, is a promising bone anabolic agent. Odanacatib, a cathepsin-K inhibitor, decreases bone resorption and reduces osteoporotic fracture risk.
Brigitte, Uebelhart, René, Rizzoli
  +14 more sources

Osteoporosis

Annals of Internal Medicine, 2017
Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. Evidence-based screening strategies improve identification of patients who are most likely to benefit from drug treatment to prevent fracture.
Kristine E. Ensrud, Carolyn J. Crandall
openaire   +4 more sources

Osteoporosis

Medical Clinics of North America, 2003
Osteoporosis has a tremendous impact on the lives of many postmenopausal women. It is encouraging that effective treatments for this disease abound and the challenge is to ensure that those most in need of diagnosis or therapy obtain adequate care. Further research is expected to clarify the role of combination therapy or sequential use of different ...
Brown, S A, Rosen, C J
openaire   +2 more sources

Osteoporosis

The Lancet, 2019
Fractures resulting from osteoporosis become increasingly common in women after age 55 years and men after age 65 years, resulting in substantial bone-associated morbidities, and increased mortality and health-care costs. Research advances have led to a more accurate assessment of fracture risk and have increased the range of therapeutic options ...
Compston, Juliet E.   +2 more
openaire   +4 more sources

Osteoporosis

Rheumatology, 1993
Osteoporosis is characterized by a reduction in bone mass and disruption of bone architecture, resulting in increased bone fragility and fracture risk, with fractures of the distal radius (Colles’ fracture), spine and proximal femur being most characteristic.
J P, Devogelaer   +1 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy